Iovance Biotherapeutics
IOVA
IOVA
167 hedge funds and large institutions have $3B invested in Iovance Biotherapeutics in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 40 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
35% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 40
9% more funds holding
Funds holding: 153 → 167 (+14)
3.95% more ownership
Funds ownership: 95.06% → 99.01% (+3.9%)
Holders
167
Holding in Top 10
12
Calls
$20.5M
Puts
$1.9M
Top Buyers
| 1 | +$116M | |
| 2 | +$65.9M | |
| 3 | +$62.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$43.1M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$25.4M |
Top Sellers
| 1 | -$67.9M | |
| 2 | -$40.1M | |
| 3 | -$30.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$24.8M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$24.5M |